Condition
Craniofacial Microsomia
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 2 (1)
Trial Status
Completed4
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05610878Phase 1Recruiting
Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting
NCT04351893Completed
Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology
NCT02224677CompletedPrimary
Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)
NCT03806361Not ApplicableCompletedPrimary
Fat Grafts With Adipose-derived Regenerative Cells for Soft Tissue Reconstruction in Children
NCT02494752Not ApplicableUnknown
Role of Mesenchymal Stem Cells in Fat Grafting
NCT01674439Phase 2CompletedPrimary
Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells
Showing all 6 trials